Australia markets closed

TherapeuticsMD Inc (29TA.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
1.79000.0000 (0.00%)
At close: 08:05AM CEST
Full screen
Previous close1.7900
Open1.7900
Bid1.7000 x N/A
Ask1.8500 x N/A
Day's range1.7900 - 1.7900
52-week range1.7900 - 4.0600
Volume24
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    TherapeuticsMD Announces Full Year 2023 Financial Results

    BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.

  • Business Wire

    TherapeuticsMD Announces Third Quarter 2023 Financial Results

    BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.

  • Business Wire

    TherapeuticsMD Announces Second Quarter 2023 Financial Results

    BOCA RATON, Fla., August 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023.